I-Sofosbuvir - Ukusetshenziswa, Isilinganiso, Imiphumela Engemihle Nokunye Okuningi

Isingeniso: Iyini iSofosbuvir?

I-Sofosbuvir umuthi wokulwa namagciwane osetshenziswa kakhulu ukwelapha ukutheleleka kwegciwane le-hepatitis C elingamahlalakhona (i-HCV). Ingowesigaba semithi eyaziwa ngokuthi ama-antiviral asebenza ngqo (ama-DAA), asebenza ngokubhekisa ezinyathelweni ezithile emjikelezweni wokuphila kwegciwane. I-Sofosbuvir ivame ukunikezwa ihlanganiswe neminye imithi yokulwa namagciwane ukuze kuthuthukiswe ukusebenza kwayo futhi kuthuthukiswe imiphumela yokwelashwa.

Ukusetshenziswa kwe-Sofosbuvir

I-Sofosbuvir ivunyelwe ukwelapha i-hepatitis C engapheli kubantu abadala kanye neziguli zezingane ezinesisindo esingaphansi kuka-17 kg (ngokuvamile - iminyaka emi-3 ubudala). Isebenza kahle ngokumelene nezinhlobo ezahlukene zegciwane, okwenza kube inketho eguquguqukayo yeziguli. Umuthi uvame ukusetshenziswa kanye neminye imithi, njenge:

• I-Ledipasvir
• I-Velpatasvir
• I-Ribavirin

kuye ngohlobo oluthile lwe-genotype kanye nesimo sempilo yesiguli. I-Sofosbuvir iboniswe ukuthi ifinyelela amazinga aphezulu okuphulukisa, ngokuvamile angaphezu kuka-90%, ezivivinyweni zemitholampilo.

Isebenza kanjani?

I-Sofosbuvir isebenza ngokuvimbela ukusebenza kwe-NS5B polymerase yegciwane le-hepatitis C, i-enzyme ebalulekile ekuphindaphindeni kwegciwane. Ngokuvimba le enzyme, i-Sofosbuvir ivimbela igciwane ukuthi lingaphindaphindeki futhi lisabalale emzimbeni. Kalula nje, ivimba igciwane ukuthi lingazakhi, okuvumela amasosha omzimba ukuthi alwe nokutheleleka ngempumelelo.

Isilinganiso nokuphathwa

I-Sofosbuvir itholakala ngesimo sethebhulethi futhi ivame ukuthathwa kanye ngosuku, ngokudla noma ngaphandle kokudla. Umthamo ojwayelekile wabantu abadala ungama-400 mg ngosuku. Ezinganeni ezineminyaka engu-12 nangaphezulu, umthamo ungahluka ngokuya ngesisindo somzimba kanye nohlelo oluthile lokwelashwa. Kubalulekile ukulandela imiyalelo yomhlinzeki wezempilo mayelana nomthamo kanye nobude bokwelashwa ukuqinisekisa umphumela ongcono kakhulu.

Imiphumela Engemihle yeSofosbuvir

Njengayo yonke imithi, i-Sofosbuvir ingabangela imiphumela emibi. Imiphumela emibi evamile ihlanganisa:

• Ukukhathala
• bekhanda
• I-nausea
• Insomnia

Imiphumela emibi kakhulu, nakuba ingajwayelekile kakhulu, ingase ihlanganise:

• Izinkinga zesibindi (isb., i-jaundice, umchamo omnyama)
• Ukusabela okukhulu kwe-allergy (isb., ukuqubuka, ukulunywa, ukuvuvukala)
• Imiphumela emibi engavamile ingafaka phakathi i-bradycardia noma izinkinga zesigqi senhliziyo (isb., nge-amiodarone)

Iziguli kufanele zibike noma yiziphi izimpawu ezingajwayelekile noma ezinzima kumhlinzeki wazo wezempilo ngokushesha.

Ukusebenzisana kwezidakamizwa

I-Sofosbuvir ingasebenzisana nemithi eminingana, okungathinta ukusebenza kwayo noma kwandise ingozi yemiphumela emibi. Ukusebenzisana okukhulu kwemithi kuhlanganisa:

• Imithi yokulwa nokuxhuzula (isib. i-carbamazepine, i-phenytoin)
• Ama-antibiotic athile (isb., i-rifampin)
• Imithi ye-HIV (isib. i-ritonavir)
• Izithasiselo zemithi (isib. i-St. John's Wort)

I-Sofosbuvir ixhumana nama-inducer e-P-gp (isib. i-rifampin, i-carbamazepine, i-phenytoin), okunciphisa ukusebenza kwayo. Kubalulekile ukuthi iziguli zazise umhlinzeki wazo wezempilo ngayo yonke imithi, izithasiselo, kanye nemikhiqizo yamakhambi eziyisebenzisayo ukuze zigweme ukusebenzisana okungenzeka.

Izinzuzo zeSofosbuvir

I-Sofosbuvir inikeza izinzuzo eziningana zezokwelapha nezisebenzayo:

• Amazinga aphezulu okuphulukiswa: Iziguli eziningi zithola impendulo ye-virologic eqhubekayo (i-SVR), okubonisa ukuthi igciwane alisabonakali egazini.
• Isikhathi sokwelashwa esifushane: Izindlela zokwelapha zivame ukuqedwa emavikini angu-8 kuya kwangu-12.
• Imiphumela emibi embalwa: Uma kuqhathaniswa nemithi yokwelapha i-hepatitis C endala, i-Sofosbuvir inemiphumela emibi emihle kakhulu.
• Ukunikezwa ngomlomo: Ukulula kokuthatha iphilisi nsuku zonke kwenza kube lula ngeziguli ukunamathela ohlelweni lwazo lokwelashwa.

Ukuphikisana kwe-Sofosbuvir

Abantu abathile kufanele bagweme ukusebenzisa iSofosbuvir, okuhlanganisa:

• Abesifazane abakhulelwe: Abesifazane abakhulelwe, ikakhulukazi ngemithi equkethe i-ribavirin.
• Iziguli ezinesifo sesibindi esibi kakhulu: Labo abane-cirrhosis engasebenzi kahle bangadinga ukwelashwa okunye.
• Abantu abanokuzwela okukhulu okwaziwayo: iSofosbuvir noma ezinye zezingxenye zayo.

Ukubonisana nomhlinzeki wezempilo kubalulekile ukuze kutholakale ukuthi iSofosbuvir iyafaneleka yini esigulini esithile.

Ukuqapha Nezexwayiso

Ngaphambi kokuqala i-Sofosbuvir, iziguli kufanele zenze izivivinyo ezithile zelebhu ukuze kuhlolwe ukusebenza kwesibindi kanye nokuba khona kwe-hepatitis C. Kubalulekile ukuqapha noma yiziphi izimpawu zezinkinga zesibindi ngesikhathi sokwelashwa. Iziguli kufanele futhi zixoxe ngomlando wazo ophelele wezokwelapha nomhlinzeki wazo wezempilo, okuhlanganisa noma yimuphi umlando wesifo sesibindi, izinkinga zezinso, noma ezinye izinkinga ezibalulekile zempilo.

Imibuzo Evame Ukubuzwa

1. I-Sofosbuvir isetshenziselwani? I-Sofosbuvir isetshenziselwa ukwelapha izifo ezingamahlalakhona ze-hepatitis C kubantu abadala kanye nezingane ezineminyaka engu-12 nangaphezulu.
2. I-Sofosbuvir ithathwa kanjani? I-Sofosbuvir ithathwa ngomlomo njengephilisi, ngokuvamile kanye ngosuku, ngokudla noma ngaphandle kokudla.
3. Yimiphi imiphumela emibi evamile? Imiphumela emibi evamile ihlanganisa ukukhathala, ikhanda elibuhlungu, isicanucanu, kanye nokungalali.
4. Ingabe iSofosbuvir ingayelapha i-hepatitis C? Yebo, iSofosbuvir ingafinyelela amazinga aphezulu okuphulukisa, ngokuvamile idlula u-90% ezivivinyweni zemitholampilo.
5. Ingabe ikhona imiphumela emibi kakhulu? Imiphumela emibi kakhulu ingafaka phakathi izinkinga zesibindi kanye nokusabela okukhulu kokungezwani komzimba.
6. Ngingayithatha iSofosbuvir kanye neminye imithi? Eminye imithi ingasebenzisana ne-Sofosbuvir. Yazisa njalo umhlinzeki wakho wezempilo ngayo yonke imithi oyiphuzayo.
7. Ingabe iSofosbuvir iphephile ngesikhathi sokukhulelwa? I-Sofosbuvir ayinconywa ukusetshenziswa ngesikhathi sokukhulelwa ngenxa yezingozi ezingaba khona embungwini.
8. Isikhathi sokwelashwa singakanani? Isikhathi sokwelashwa ngokuvamile sisukela emavikini angu-8 kuya kwangu-12, kuye ngohlobo oluthile lokwelashwa.
9. Yini okufanele ngiyenze uma ngiphuthelwa umthamo? Uma uphuthelwa umthamo, thatha ngokushesha nje lapho ukhumbula. Uma sekuyisikhathi somthamo wakho olandelayo, yeqa umthamo ophuthelwe bese uqhubeka nesimiso sakho esijwayelekile. Ungaphindi kabili umthamo.
10. Ngingaphuza yini utshwala ngenkathi ngithatha iSofosbuvir? Kunconywa ukugwema utshwala, ngoba bungadala umonakalo wesibindi futhi buphazamise ukwelashwa.

Amagama Omkhiqizo

I-Sofosbuvir ithengiswa ngaphansi kwamagama emikhiqizo eminingana, okuhlanganisa:

• I-Sovaldi (i-sofosbuvir monotherapy)
• I-Epclusa (inhlanganisela yomthamo ohleliwe ne-velpatasvir)
• I-Harvoni (inhlanganisela yomthamo ohleliwe ne-ledipasvir)

Isiphetho

I-Sofosbuvir iyimithi evelele ekwelapheni i-hepatitis C engapheli, enikeza amazinga aphezulu okuphulukisa kanye nohlelo lokwelapha olulawuleka kalula uma kuqhathaniswa nezindlela zokwelapha ezindala. Indlela esebenza ngayo imisa ngempumelelo ukuphindaphindana kwegciwane, okuvumela iziguli ukuthi ziphinde zithole impilo yazo. Kodwa-ke, kubalulekile ukubonisana nomhlinzeki wezempilo ukuze kutholakale uhlelo lokwelapha olungcono kakhulu nokuqapha noma yimiphi imiphumela emibi engaba khona noma ukusebenzisana.